comparemela.com
Home
Live Updates
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS : comparemela.com
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team...
Related Keywords
United States
,
Sydney
,
New South Wales
,
Australia
,
John Friend
,
Genentech
,
Safety Review Team
,
Kazia Therapeutics Limited
,
Kazia Therapeutics
,
Exchange Commission
,
Prnewswire Kazia Therapeutics Limited
,
Therapeutics Limited
,
Orphan Drug Designation
,
Rare Pediatric Disease Designation
,
Annual Report
,
United States Securities
,
comparemela.com © 2020. All Rights Reserved.